2022
DOI: 10.1016/j.mad.2022.111674
|View full text |Cite
|
Sign up to set email alerts
|

Routine laboratory parameters, including complete blood count, predict COVID-19 in-hospital mortality in geriatric patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

5
19
1
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 23 publications
(26 citation statements)
references
References 72 publications
5
19
1
1
Order By: Relevance
“…Previous clinical studies have reported that dNLR ( 25 ), NLR ( 26 ), SII ( 27 ), SIRI ( 28 ), PLR ( 29 ), MLR ( 30 ), were valuable for the prognosis of COVID-19 patients. However, the use of ROC analysis to evaluate the predictive power of inflammatory markers (considering time dependence) has not been fully addressed for COVID-19 Omicron BA.2.…”
Section: Discussionmentioning
confidence: 99%
“…Previous clinical studies have reported that dNLR ( 25 ), NLR ( 26 ), SII ( 27 ), SIRI ( 28 ), PLR ( 29 ), MLR ( 30 ), were valuable for the prognosis of COVID-19 patients. However, the use of ROC analysis to evaluate the predictive power of inflammatory markers (considering time dependence) has not been fully addressed for COVID-19 Omicron BA.2.…”
Section: Discussionmentioning
confidence: 99%
“…Notably, sNfL levels were not correlated with the most common routinary analyzed biomarkers that we identified as associated with increased short-term mortality risk in this setting of patients in our previous report, i.e. neutrophil, lymphocyte, and eosinophil count, blood glucose, C-reactive protein, procalcitonin, and ferritin [ 12 ].…”
mentioning
confidence: 68%
“…The present study was performed on a subset of samples from the already published Report-Age COVID observational study, which was conducted at the Italian National Center on Aging (IRCCS INRCA, Ancona, Italy) to understand the predictors of adverse outcomes in older patients hospitalized and diagnosed with COVID-19 [ 12 ]. Samples were collected between 1st March 2020 and 24th June 2021.…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…This finding has generated great interest in employing these indexes as biomarkers to establish prognosis and appropriate level of care, particularly because they are cheap and easily evaluated through routine blood tests [ 24 , 25 ]. In particular, the neutrophil-to-lymphocyte ratio (NLR), derived NLR (dNLR), systemic inflammation index (SII), and aggregate index of systemic inflammation (AISI) have so far produced the most promising evidence in terms of their potential use for early risk stratification of COVID-19 patients [ 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 ].…”
Section: Introductionmentioning
confidence: 99%